Results 121 to 130 of about 6,536 (205)

Molecular Pathophysiology of Autosomal Recessive Polycystic Kidney Disease. [PDF]

open access: yesInt J Mol Sci, 2021
Cordido A   +2 more
europepmc   +1 more source

Evaluation of galectin-3 and intestinal fatty acid binding protein as serum biomarkers in autosomal recessive polycystic kidney disease. [PDF]

open access: yesJ Nephrol, 2023
Fleischer LT   +7 more
europepmc   +1 more source

Reduction of elevated Gli3 does not alter the progression of autosomal recessive polycystic kidney disease. [PDF]

open access: yesPhysiol Rep
Russell LG   +11 more
europepmc   +1 more source

Ameliorating liver disease in an autosomal recessive polycystic kidney disease mouse model.

open access: yesAm J Physiol Gastrointest Liver Physiol, 2023
Yanda MK, Zeidan A, Cebotaru L.
europepmc   +1 more source

Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney Disease. [PDF]

open access: yesCell Mol Gastroenterol Hepatol, 2021
Yanda MK, Tomar V, Cebotaru L.
europepmc   +1 more source

Autosomal Recessive Polycystic Kidney Disease and Epidemiologic Factors

open access: diamond, 2017
Parsa Yousefichaijan   +2 more
openalex   +1 more source

Refining genotype–phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1 gene variants

open access: green, 2021
Kathrin Burgmaier   +99 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy